Baricitinib
Fighting COVID-19: New Zealand secures another medicine
Wellington/UNI/Xinhua: The addition of another drug to the suite of COVID-19 medicines available in New Zealand is good news for patients and for the health system, Health Minister Andrew Little said on Friday.
The national pharmaceuticals-buying agency Pharmac has secured supplies of another drug "Baricitinib" shown to work against the COVID-19 virus, Little said in a statement.
"Baricitinib is the fifth drug Pharmac has secured, and sits alongside remdesivir, tocilizumab, molnupiravir and Ronapreve as treatments doctors can turn to help people with a range of COVID-19 symptoms," he said.
Like tocilizumab, baricitinib can be used to treat patients who are very sick, as it reduces the severity of symptoms and cuts time in hospital and reduces the likelihood of death, he added.
Pharmac expects to receive 500 doses of baricitinib this month, which is important because there is a global shortage of tocilizumab and this gives clinicians another option, said the minister.
Money for all five medicines will come from the government's COVID-19 fund. It has yet to be approved by Medsafe for use against COVID-19, but clinicians will be able to use it straight away under Section 25 of the Medicines Act, he said.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
